| Literature DB >> 30415268 |
Lan Lan1, Yanyi Cen1, Canzhou Zhang1, Yuan Qiu2,3, Baoyi Ouyang1.
Abstract
BACKGROUND Most observations of non-intubated anesthesia under spontaneous breathing are small-cohort, non-homogeneous surgery types and lack an intubation control. We therefore retrospectively compared the perioperative conditions and postoperative recovery of non-intubated video-assisted thoracoscopic surgery (NIVATS group) and intubated VATS (IVATS group) with a propensity score-matching analysis. MATERIAL AND METHODS We case-matched 119 patients in the NIVATS group with patients in the IVATS group by a propensity score-matched analysis. All of them underwent lobectomy. RESULTS In the NIVATS group, operative and anesthesia times were significantly shorter (P<0.01). NIVATS showed a faster and more stable recovery in the PACU, postoperative awaking and post-anesthesia care unit (PACU) stay times was shorter (P<0.01), and use of sedatives and analgesics was lower (P<0.05). The incidence of pulmonary exudation, atelectasis, and pleural effusion were higher (P<0.05). Although intraoperative SpO2 was lower and PETCO2 was higher in the NIVATS group (P<0.01), postoperative PaCO2 and SaO2 in both groups were similar (P>0.05). Postoperative counts of leukocytes and neutrophils and hemoglobin levels also had no difference between the 2 groups (P>0.05). CONCLUSIONS NIVATS has a more rapid and stable recovery in the PACU, and has no significant influence on oxygenation, but is more likely to cause postoperative radiologic complications.Entities:
Mesh:
Year: 2018 PMID: 30415268 PMCID: PMC6410560 DOI: 10.12659/MSM.910605
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Preoperative patients’ characteristic of VATS lobectomy after matching.
| Variable | IVATS group (n=119) | NIVATS group (n=119) | P value |
|---|---|---|---|
| Age (years) | 55.34±13.83 | 56.98±11.05 | 0.311 |
|
| |||
| Gender (M/F) | 68/51 | 69/50 | 0.896 |
|
| |||
| Body mass index (Kg/m2) | 22.40±2.85 | 22.51±2.57 | 0.756 |
|
| |||
| ASA physical status class (N. [%]) | 0.623 | ||
| I | 95 (79.8) | 98 (82.4) | |
| II | 23 (19.3) | 20 (16.8) | |
| III | 1 (0.8) | 1 (0.8) | |
|
| |||
| Comorbidity (N. [%]) | 0.290 | ||
| Cardiovascular diseases | 9 (7.6) | 8 (6.7) | |
| Diabetes | 4 (3.4) | 6 (5.0) | |
| Pulmonary diseases | 7 (5.9) | 2 (1.7) | |
| Prior Thoracic Surgery | 4 (3.4) | 1 (0.8) | |
| None | 95 (79.8) | 102 (85.7) | |
|
| |||
| LVEF | 71.40±6.43 (n=92) | 71.68±5.90 (n=107) | 0.749 |
|
| |||
| Cardiac Risk index (N. [%]) | 0.562 | ||
| 1 point | 117 (98.3) | 118 (99.2) | |
| 2 points | 2 (1.7) | 1 (0.8) | |
|
| |||
| Preoperative hospital stay (d) | 9 (7, 13) | 8 (5, 12) | 0.934 |
|
| |||
| Preoperative Leukocyte (×109) | 6.86±1.96 | 6.46±1.83 | 0.104 |
|
| |||
| Preoperative Neutrophil (%) | 59.43±11.92 | 59.36±9.50 | 0.960 |
|
| |||
| Preoperative Hemoglobin (g) | 134.08±15.10 | 132.77±14.239 | 0.494 |
|
| |||
| Pulmonary function tests (%) | |||
| FVC% predicted | 97.70±17.04 (n=82) | 96.56±17.35 (n=110) | 0.649 |
| FEV1% predicted | 90.74±20.74 (n=82) | 90.96±16.64 (n=110) | 0.935 |
| FEV1/FVC | 92.40±19.60 (n=82) | 97.61±10.45 (n=110) | 0.019 |
Intraoperative variables.
| Variables | IVATS group (n=119) | NIVATS group (n=119) | P value |
|---|---|---|---|
| Pathologic diagnosis (N. [%]) | 0.000 | ||
| Benign/malignant | 37 (31.1)/82 (68.9) | 10 (8.4)/109 (91.6) | 0.000 |
| Primary/metastatic | 80 (97.6)/2 (2.4) | 106 (97.2)/3 (2.8) | 0.487 |
|
| |||
| Surgical location (N. [%]) | 1.000 | ||
| Left/right lung | 44 (37.0)/75 (63.0) | 44 (37.0)/75 (63.0) | |
|
| |||
| The number of lobes involved in surgery (N. [%]) | 0.270 | ||
| Upper lobe | 50 (42.0) | 57 (47.9) | |
| Middle lobe | 7 (5.9) | 7 (5.9) | |
| Lower lobe | 53 (44.5) | 50 (42.0) | |
| Two lobes | 9 (7.6) | 5 (4.2) | |
|
| |||
| Operative time (min) | 217.64±59.71 | 175.63±55.67 | 0.000 |
|
| |||
| Anesthesia time (min) | 301.87±63.69 | 250.63±55.67 | 0.000 |
|
| |||
| Blood loss (ml) | 100 (50, 300) | 50 (30, 120) | 0.000 |
|
| |||
| The amount of liquid infusion (ml) | 1822.29±536.64 | 2105.04±520.24 | 0.000 |
|
| |||
| Urine volume (ml) | 700 (488, 1000) | 850 (700, 1000) | 0.002 |
|
| |||
| The lowest intraoperative SpO2 (%) | 99.10±1.75 | 97.12±3.19 | 0.000 |
|
| |||
| The highest intraoperative PETCO2 (mmHg) | 37.93±3.50 | 48.02±8.90 | 0.000 |
Anesthesia time began from the first electronically monitored observation in the operation room to until the time the patient was transferred to PACU. Operative time was comprised between skin incision and completion of skin closure.
Early recovery in Post-Anesthesia Care Unit.
| Variables | IVATS group (n=119) | NIVATS group (n=119) | P value |
|---|---|---|---|
| Extubation time (min) | 30.92±9.07 (n=119) (Double-lumen tube) | 20.38±6.28 (n=13) (Laryngeal mask) | 0.000 |
|
| |||
| Post-operative awaking time (min) | 46.89±10.54 | 21.48±6.74 | 0.000 |
|
| |||
| Vital signs before leaving PACU | |||
| HR (bpm) | 81.77±10.96 | 79.71±10.44 | 0.139 |
| MAP (mmHg) | 81.63±12.29 | 78.51±12.35 | 0.052 |
| SpO2 (%) | 99.13±0.82 | 99.24±0.83 | 0.310 |
|
| |||
| Drugs usage in PACU (N. [%]) | |||
| Neostigmine + atropine | 82 (68.9) | 0 (0.0) | 0.142 |
| Sedatives (midazolam, propofol) | 27 (22.7) | 14 (11.8) | 0.000 |
| Analgesics (tramadol, opioids, NSAIDs) | 47 (39.5) | 24 (20.2) | 0.002 |
| Naloxone | 2 (1.7) | 3 (2.5) | 0.000 |
| Flumazenil | 0 (0.0) | 4 (3.4) | 0.330 |
| Urapidil | 17 (14.3) | 6 (5.0) | 0.001 |
|
| |||
| Staying in PACU time (min) | 61.60±10.27 | 37.24±7.27 | 0.000 |
Staying in PACU time was defined as the time from arrival in the PACU until the patient was discharged to the ward.
Postoperative chest radiography results.
| Variables | IVATS group (n=119) | NIVATS group (n=119) | P value |
|---|---|---|---|
| Chest radiograph results (N. [%]) | 0.009 | ||
| Normal | 95 (79.8) | 78 (65.5) | 0.000 |
| Pulmonary exudation | 11 (9.2) | 18 (15.1) | 0.025 |
| Atelectasis | 3 (2.5) | 19 (16.0) | 0.000 |
| Pleural effusion | 2 (1.7) | 0 | 0.000 |
| Pneumonitis | 3 (2.5) | 2 (1.7) | 0.426 |
| Two or more kinds of results | 5 (4.2) | 2 (1.7) | 0.119 |
Figure 1Changes in routine blood cells analysis of IVATS group and NIVATS group before and after the operation. # P values shown are for the comparison of pre-operation and post-operation in IVATS group. @vP values shown are for the comparison of pre-operation and post-operation in NIVATS group.
Figure 2Changes in postoperative blood gas values in IVATS group and NIVATS group. * P values shown are for the comparison between IVATS group and NIVATS group after the operation.